Recovery News | Mental Health & Addiction Recovery

Protecting Kidneys in Bipolar Disorder: The Unexpected GLP-1 Finding

New Mayo Clinic research, published in the Journal of Affective Disorders, finds that people with bipolar disorder and early-stage kidney disease who used GLP-1 drugs had a lower risk of progressing to dialysis or needing a kidney transplant — an especially promising signal given that lithium, a mainstay bipolar treatment, can strain the kidneys over time.

Source